secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hims & Hers Health, Inc. (HIMS)
CIK:        0001773751
Form:       8-K
Filed at:   2023-02-23T23:59:59+00:00
Accession:  0001773751-23-000015
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Hims & Hers appoints Christiane Pendarvis to board of directors
---------------------------------------------------------------

- Board expanded from 10 to 11 directors; Pendarvis fills newly created vacancy effective Feb 16, 2023.
- Pendarvis, 52, deemed independent under NYSE and SEC rules; no committee assignment yet.
- She will serve until the 2023 annual meeting; compensation per standard director program.
- No family relationships with any director or executive officer; no transactions requiring disclosure.
- Pendarvis will enter the company's standard indemnification agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1773751/000177375123000015/0001773751-23-000015-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1773751/000177375123000015/hims-20230216.htm
  HTML page:      https://secwatch.observer/filing/0001773751-23-000015

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer